technetium tc-99m tetrofosmin kit (Myoview) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

99mtc-tetrafosmin | 99mtc tetrofosmin | 99mtc-tetrofosmin | myoview | myoview 30ml | ppn1011 | ppn-1011 | tc-99m-ppn1011 | tc99m tetrafosmin | tc-99m tetrofosmin | tc-99m-tetrofosmin | tc99m tetrofosmin | technetium(1+)-99tc, bis(6,9-bis(2-ethoxyethyl)-3,12-dioxa-6,9-diphosphatetradecane-.kappa.p,.kappa.p')dioxo-, (oc-6-11)- | technetium (99mtc) tetrofosmin | technetium-99m-tetrofosmin | technetium-99 tetrofosmin | technetium tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane | technetium tc 99m tetrofosmin | technetium tc-99m tetrofosmin | technetium tc-99m tetrofosmin kit | technetium tetrofosmin

Organizations (3)

Research & Development (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (1)


 

Diagnostic Imaging (approved 1996)

Experimental Indications - Clinical Trial Phases 1-4 (1)


 

Coronary Artery Disease (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial Organizations: 3

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue